<DOC>
	<DOCNO>NCT00132912</DOCNO>
	<brief_summary>The object study determine whether different dos SCH 530348 , add standard medical care person undergo percutaneous coronary intervention , increase risk bleed . A secondary objective determine whether patient treat SCH 530348 few cardiac event heart attack , bypass surgery , death compare person treat standard care .</brief_summary>
	<brief_title>Safety SCH 530348 Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention ( Study P03573 )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Vorapaxar</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>A person 45 year old mentally competent provide sign write informed consent . A person schedule undergo percutaneous coronary intervention heart catheterization intent undergo percutaneous coronary intervention . If woman childbearing potential ( ie , menopause ) , must test negative pregnancy agree use reliable method birth control . Pregnancy Recent stroke Active internal bleeding history bleed disorder Increased risk bleeding Severe high blood pressure Liver kidney disease Low platelet count Condition alcoholism , mental illness , drug dependence Ongoing chest pain Planned ongoing treatment blood thin medication A serious condition illness would interfere participation study</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Platelets</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Protease-Activated Receptor 1</keyword>
	<keyword>Hemorrhage</keyword>
</DOC>